Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
2.080
-0.040 (-1.89%)
May 20, 2025, 9:33 AM - Market open
Fractyl Health Employees
Fractyl Health had 107 employees as of December 31, 2024. The number of employees increased by 5 or 4.90% compared to the previous year.
Employees
107
Change (1Y)
5
Growth (1Y)
4.90%
Revenue / Employee
$561
Profits / Employee
-$832,776
Market Cap
101.87M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107 | 5 | 4.90% |
Dec 31, 2023 | 102 | 19 | 22.89% |
Dec 31, 2021 | 83 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
GUTS News
- 1 day ago - Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes - GlobeNewsWire
- 3 days ago - Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025 - GlobeNewsWire
- 6 days ago - Forge Biologics Announces AAV Development and cGMP Manufacturing Relationship with Fractyl Health to Advance Their Gene Therapy Platform for Patients with Metabolic Diseases - Business Wire
- 6 days ago - Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 14 days ago - Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference - GlobeNewsWire
- 21 days ago - Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting - GlobeNewsWire
- 7 weeks ago - Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation - GlobeNewsWire